Beste Calimlioglu Turanli
Marmara Üniversitesi
H-index: 18
Asia-Turkey
Top articles of Beste Calimlioglu Turanli
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Genome-scale metabolic models in translational medicine: the current status and potential of machine learning in improving the effectiveness of the models | Beste Turanli Gizem Gulfidan Ozge Onluturk Aydogan Ceyda Kula Gurudeeban Selvaraj | 2024 | |
Comparative analysis of diisononyl phthalate and di(isononyl)cyclohexane-1,2 dicarboxylate plasticizers in regulation of lipidmetabolism in 3T3-L1 cells | Environmental Toxicology | Ceyhun Bereketoglu Isabel Häggblom Beste Turanlı Ajay Pradhan | 2024/3 |
Decoding Systems Biology of Inflammation Signatures in Cancer Pathogenesis: Pan-Cancer Insights from 12 Common Cancers | OMICS: A Journal of Integrative Biology | Beste Turanli | 2023/10/1 |
P345: IN SILICO DRUG REPURPOSING STUDY AND MOLECULAR SIGNATURE IDENTIFICATION ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA | HemaSphere | Yagmur Kiraz Durmaz Betül Budak Ezgi Yağmur Tükel Beste Turanli | 2023/8/1 |
Idiopathic Pulmonary Fibrosis Molecular Substrates Revealed by Competing Endogenous RNA Regulatory Networks | OMICS: A Journal of Integrative Biology | Muhammed Fatih Kircali Beste Turanli | 2023/8/1 |
Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors | Journal of Endocrinological Investigation | Aydin B Beklen H Arga KY Bayrakli F Turanli B | 2022/10/28 |
DCDA: CircRNA–Disease Association Prediction with Feed-Forward Neural Network and Deep Autoencoder | Interdisciplinary Sciences: Computational Life Sciences | Hacer Turgut Beste Turanli Betül Boz | 2023/11/17 |
Systems biomarkers for papillary thyroid cancer prognosis and treatment through multi-omics networks | Archives of Biochemistry and Biophysics | Gizem Gulfidan Melisa Soylu Damla Demirel Habib Burak Can Erdonmez Hande Beklen | 2022/1/15 |
Transcriptomics-based drug repurposing unravels novel therapeutic strategies in AML | BESTE TURANLI KAZIM YALÇIN ARĞA BETÜL YILMAZ | 2022/11/16 | |
Prospects of integrated multi-omics-driven biomarkers for efficient hair loss therapy from systems biology perspective | Dilan Nisa Yilmaz Ozge Onluturk Aydogan Medi Kori Busra Aydin Md Rezanur Rahman | 2022/9/1 | |
Acute myeloid leukemia: New multiomics molecular signatures and implications for systems medicine diagnostics and therapeutics innovation | OMICS: A Journal of Integrative Biology | Nurdan Kelesoglu Medi Kori Beste Turanli Kazim Yalcin Arga Betul Karademir Yilmaz | 2022/7/1 |
Repositioning of Anti-Inflammatory Drugs for the Treatment of Cervical Cancer Sub-Types | Frontiers in Pharmacology | Medi Kori Kazim Yalcin Arga Adil Mardinoglu Beste Turanli | 2022/6/13 |
Past, present, and future of therapies for pituitary neuroendocrine tumors: need for omics and drug repositioning guidance | Busra Aydin Esra Yildirim Onur Erdogan Kazim Yalcin Arga Betul Karademir Yilmaz | 2022/3/1 | |
Current State of “Omics” Biomarkers in Pancreatic Cancer | Beste Turanli Esra Yildirim Gizem Gulfidan Kazim Yalcin Arga Raghu Sinha | 2021/2/14 | |
Rahim Ağzı Kanser Alt-Tiplerine Özgü Moleküler Hedef, Biyoişaretçi Adaylar ve Yeniden Konumlandırılan İlaçların Belirlenmesi | Int. J. Adv. Eng. Pure Sci. | Beste Turanli | 2021 |
Differential protein interactome in esophageal squamous cell carcinoma offers novel systems biomarker candidates with high diagnostic and prognostic performance | OMICS: A Journal of Integrative Biology | Gizem Gulfidan Hande Beklen Indu Sinha Fulya Kucukalp Buse Caloglu | 2021/8/1 |
Differential interactome based drug repositioning unraveled abacavir, exemestane, nortriptyline hydrochloride, and tolcapone as potential therapeutics for colorectal cancers | Frontiers in Bioinformatics | Hande Beklen Sema Arslan Gizem Gulfidan Beste Turanli Pemra Ozbek | 2021/9/14 |
Systems biology based drug repositioning for development of cancer therapy | Beste Turanli Ozlem Altay Jan Borén Hasan Turkez Jens Nielsen | 2021/1 | |
Systems-level biomarkers identification and drug repositioning in colorectal cancer | Hande Beklen Esra Yildirim Medi Kori Beste Turanli Kazim Yalcin Arga | 2021/7/7 | |
The repertoire of glycan alterations and glycoproteins in human cancers | Medi Kori Busra Aydin Gizem Gulfidan Hande Beklen Nurdan Kelesoglu | 2021/3/1 |
Co-Authors
